DALLAS JAYSON DONALD ALEXANDER (President and CEO) reported 1 transaction at AIMMUNE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/16/2020ACC: 0000899243-20-025345
DirectorOfficer· President and CEO
Since Nov 2018
-1.64K
Net shares
Net seller
$56.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.64K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.64K
Price / share
$34.25
Trade value
$56.24K
% of position
1.4%
9/15/2020
118.68K→117.03K
Total
Net shares
−1.64K
Net value
-$56.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 9/15/2020 | F · Tax Withholding | −1.64K | $34.25 | $56.24K | 1.4% | 118.68K | 117.03K |
| Total | −1.64K | -$56.24K | ||||||
Derivative Transactions0
No derivative transactions reported